The Silverstein Foundation Launches Post-Doctoral Fellowship Program to Fund Novel Research for Parkinson’s Disease in GBA Mutation Carriers
The Silverstein Foundation for Parkinson’s with GBA (“Silverstein Foundation”) today announced the creation of a two-year, post-doctoral fellowship program that will fund eleven scientists engaged in cutting-edge research on Parkinson’s disease in GBA mutation carriers (GBA-PD) in academic and hospital-based laboratories around the world.
- The Silverstein Foundation for Parkinson’s with GBA (“Silverstein Foundation”) today announced the creation of a two-year, post-doctoral fellowship program that will fund eleven scientists engaged in cutting-edge research on Parkinson’s disease in GBA mutation carriers (GBA-PD) in academic and hospital-based laboratories around the world.
- “The goal of this two-year program is to fund the next generation of elite researchers who will devote their time to finding novel, diverse approaches to analyze, prevent and treat GBA-PD,” said Jonathan Silverstein, founder of the Silverstein Foundation and a retired Managing Partner and former Co-Head of Private Equity at OrbiMed.
- Silverstein added, “These researchers will meet regularly to collaborate and share findings with each other.
- Furthermore, these findings will be made public to the broader GBA-PD community through publications and presentations at scientific conferences worldwide.